Pilot HPV Vaccination in Chinese American Community

Developing and Pilot Testing a Multilevel HPV Vaccination Intervention in Chinese American Community

This study provides a pioneer model in increasing knowledge of HPV vaccination among Chinese American families through culturally tailored interventions, and eventually increase the HPV vaccine uptake among Chinese American adolescents.

Study Overview

• Status: Completed
• Conditions: HPV
• Intervention / Treatment: Behavioral: Interventional HPV vaccination video modules; Behavioral: General Vaccination Education

• Study Type: Interventional
• Enrollment (Actual): 170
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Pennsylvania
    • Philadelphia, Pennsylvania, United States, 19140
      • Center for Asian Health, Lewis Katz School of Medicine, Temple University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

1. Self-identified Chinese Parents or legal guardian with children aged 11-18 years old;
2. The children have not received any does of HPV vaccination

Exclusion Criteria:

-

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Intervention Group with active education; The study team provides participants in the intervention group with interventional education, using interactive video watch and dynamic discussion.	Behavioral: Interventional HPV vaccination video modules; The study team provide participants in the intervention group with interventional education, using interactive video watch and dynamic discussion. The educational videos were aiming to reinforcement and improvement the awareness, knowledge, attitude, intention and actual uptake of HPV vaccination shots among Chinese parents.
Active Comparator: Control Group with handouts; The study team provides the participants in the control group with education, using only handouts of vaccinations including HPV, but not using interactive video watch and dynamic discussion	Behavioral: General Vaccination Education; Education session conducted using only handouts of vaccinations including HPV

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
changes from baseline HPV vaccine uptake rate at 6-month follow up	the rate of getting HPV vaccination uptake 6 months post intervention	baseline, and 6-month follow up

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
change of HPV knowledge from baseline to 6-month follow up	Knowledge scores ranged from 0 to 7, computed by taking the total number of correct answers to the questions with a higher numeric value indicating better knowledge	baseline, and 6-month
change in adolescents engagement percentage	change in the percents of engaging adolescents in decision-making at post intervention	baseline, and 6-month

Collaborators and Investigators

• Sponsor: Temple University
• Collaborators: National Cancer Institute (NCI)

Study record dates

Study Major Dates

• Study Start (Actual): April 27, 2015
• Primary Completion (Actual): August 31, 2017
• Study Completion (Actual): August 31, 2017

Study Registration Dates

• First Submitted: July 23, 2020
• First Submitted That Met QC Criteria: August 6, 2020
• First Posted (Actual): August 10, 2020

Study Record Updates

• Last Update Posted (Actual): April 13, 2023
• Last Update Submitted That Met QC Criteria: April 11, 2023
• Last Verified: April 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: Pilot HPV Vaccination; U54CA153513 (U.S. NIH Grant/Contract)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No